lobbying_activities: 3806520

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
3806520	9c34701c-f71d-4d65-81bc-130fe4e15d4b	Q1	SYENSQO USA LLC	400408933	SYENSQO USA LLC	2026	first_quarter	FOO	S. 3122, Better FDA Act of 2025, including provisions related to modifications to FDA's oversight of the "Generally Recognized as Safe" framework. Make America Healthy Again Commission report, dated Sep. 9, 2025, under Executive Order 14212 titled "Establishing the President's Make America Healthy Again Commission," including provisions related to guidance on water contaminants and the generally recognized as safe (GRAS) process. Proposed rule from the U.S. Food and Drug Administration on Substances Generally Recognized as Safe.	Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),SENATE		350000	0	0	2026-04-13T14:19:58-04:00